The increase in spending on R&D activities is what is fuelling the growth of nucleic acid isolation and purification market. The key players are covered in the report with their sales, revenues and strategies are QIAGEN N.V., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Promega Corporation, Agilent Technologies, Bio-Rad Laboratories, Danaher Corporation, G.E. Healthcare, Illumina Inc., Merck KGaA, Takara Bio, Zymo Research, New England Biolabs, NorgenBiotek Corp, Omega Bio-tek, and Others.
NEW YORK, United States, Oct. 05, 2022 (GLOBE NEWSWIRE) -- According to Facts and Factors has published a new research report titled “Nucleic Acid Isolation And Purification Market Size, Share, Growth Analysis Report By Product (Kits, Reagents, Instrument), By Type (Plasmid DNA Isolation and Purification, Total RNA Isolation and Purification, Circulating Nucleic Acid Isolation and Purification, Genomic DNA Isolation and Purification, Messenger RNA Isolation and Purification, microRNA Isolation and Purification, PCR Cleanup, Other Nucleic Acid Isolation and Purification Types), By Method (Column-based Isolation and Purification, Magnetic Bead-based Isolation and Purification, Reagent-based Isolation and Purification, Other Isolation and Purification Methods), By Application (Diagnostics, Drug Discovery & Development, Personalized Medicine, Agriculture & Animal Research, Other Applications), By End User (Hospitals & Diagnostic Centers, Academic & Government Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Other End Users), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028” in its research database.
“According to the latest research study, the demand of global Nucleic Acid Isolation And Purification Market size & share in terms of revenue was valued at USD 4392.5 Million in 2021 and it is expected to surpass around USD 8260.30 Million mark by 2028, growing at a compound annual growth rate (CAGR) of approximately 11.10% during the forecast period 2022 to 2028.”
Nucleic acids must be extracted and purified for various medical applications, such as drug development, research, and other uses. The finest quality and purest nucleic acids, such as DNA and RNA, are required for a wide range of scientific and clinical uses. DNA or RNA must be separated and purified for forensic, medical, scientific, and genetic research objectives.
The procedure is carried out using a variety of techniques, such as reagent-based techniques, column-based techniques, and others. Some examples of potential sources for nucleic acid isolation and purification include hair, blood, bones, sperm, saliva, nails, and urine.
Click Here To AccessFree Sample Report of the Global Nucleic Acid Isolation And Purification Market @ https://www.fnfresearch.com/sample/nucleic-acid-isolation-and-purification-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the Following:
Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
Provide detailed chapter-by-chapter guidance on Request
Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
Includes Tables and figures have been updated
The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
Facts and Factors research methodology
The market for nucleic acid separation and purification will grow due to developments in medical technology, expanding awareness-raising campaigns by both public and private groups, and rising government support. The nucleic acid isolation and purification market are anticipated to rise with lucrative chances due to the great potential for development in the advancing market, the improving regulating and repaying environment, molecular diagnostics and individualized treatment. This report on the global nucleic acid isolation and purification market details recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/nucleic-acid-isolation-and-purification-market
The nucleic acid isolation & purification market has been segmented into product, type, method, application, end-user and region.
Based on product, the market has been segmented into kits, reagents, and instruments. The kits segment dominated in 2021. Based on type, the market is segmented as plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, other nucleic acid isolation and purification types. The circulating nucleic acid isolation and purification segment are expected to grow during the forecast period in 2021.
Based on methods, the market is segmented as column-based isolation and purification, magnetic bead-based isolation and purification, reagent-based isolation and purification, and other isolation and purification methods. The major portion of this market in 2021 was devoted to column-based isolation and purification. Based on application, the market is segmented into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research and other applications. The diagnostics segments dominated the market in 2021.
Based on end-user, the market is segmented into hospitals & diagnostic centers, academic & government research institutes, pharmaceutical & biotechnology companies, contract research organizations and other end users. The hospitals & diagnostic centers segment dominated the market in 2021.
The global Nucleic Acid Isolation And Purification market is segmented as follows:
Plasmid DNA Isolation and Purification
Total RNA Isolation and Purification
Circulating Nucleic Acid Isolation and Purification
Genomic DNA Isolation and Purification
Messenger RNA Isolation and Purification
Other Nucleic Acid Isolation and Purification Types
Magnetic Bead-based Isolation and Purification
Other Isolation and Purification Methods
Academic & Government Research Institutes
Browse the full “Nucleic Acid Isolation And Purification Market Size, Share, Growth Analysis Report - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028” Report at https://www.fnfresearch.com/nucleic-acid-isolation-and-purification-market
Some of the main competitors dominating the global Nucleic Acid Isolation And Purification market include -
3B BlackBio Biotech India Limited
Key Insights from Primary Research:
According to research, the Nucleic Acid Isolation And Purification market is likely to expand at a CAGR of around 11.10% during the forecast period (2022-2028).
In terms of revenue, the Nucleic Acid Isolation And Purification market size was valued at around US$ 4392.5 Million in 2021 and is projected to reach US$ 8260.30 Million by 2028.
Based on type, the circulating nucleic acid isolation and purification segment are expected to grow during the forecast period in 2021.
Based on methods, the major portion of this market in 2021 was devoted to column-based isolation and purification.
On the basis of region, the “North America” region was the leading revenue generator in 2021.
Market Size & Forecast by Revenue | 2022−2028
Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
Market Segmentation – A detailed analysis By Product, Type, Method, Application, End User, and Region
Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Request for Customization on this Report as per your requirements - https://www.fnfresearch.com/customization/nucleic-acid-isolation-and-purification-market
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
In 2021 North America will hold the largest market share. Established companies' initiatives to develop technologically advanced quick purification and isolation systems are the primary factors driving market expansion in the region. Additionally, the market's expansion in this field is being sped up by rising financing initiatives for biotechnology research. On the other hand, the Asia Pacific region is likely to experience the highest CAGR growth throughout the forecast decade. Rising economic growth, extensive life sciences research, an increase in the number of patients, supporting government policies, and several innovative biotech businesses in the area contribute to the region's thriving market.
The Middle East & Africa
Rest of the Middle East & Africa
In 2022, Thermo Fisher committed USD 97 Million to expand its Richmond, Virginia-based clinical research company. The facility's top-notch bioanalytical lab capabilities will support clinical research activities.
QIAGEN N.V., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Promega Corporation, Agilent Technologies, Bio-Rad Laboratories, Danaher Corporation, G.E. Healthcare, Illumina Inc., Merck KGaA, Takara Bio, Zymo Research, New England Biolabs, NorgenBiotek Corp, Omega Bio-tek, Gena8260.30on Bioscience GmbH, 3B BlackBio Biotech India Limited, Invitek Molecular, BioVision, Analytik Jena AG., and Others
By Product, Type, Method, Application, End User, and Region
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa
Request customized purchase options to meet your research needs.
Browse Other Related Research Reports from Facts & Factors:
Global Cosmetic Preservatives Market Share is Likely to Grow at a CAGR Value of 6.20 % By 2028: https://www.fnfresearch.com/cosmetic-preservatives-market
Global Trifluoroacetic Acid Market Share Is Likely To Reach At A CAGR Value Of Around 2.9% By 2028: https://www.fnfresearch.com/trifluoroacetic-acid-market
Global Acetic Acid Market Share Is Expected to Grow At A CAGR Value Of Around 4.01% By 2028: https://www.fnfresearch.com/acetic-acid-market
Global Wrinkle Fillers Market Share Is Expected to Grow At A CAGR Value Of Around 9.20% By 2028: https://www.fnfresearch.com/wrinkle-fillers-market
Global Propionic Acid Market Share Is Likely To Reach At A CAGR Value Of Around 3.3% By 2028: https://www.fnfresearch.com/propionic-acid-market
Global Nitric Acid Market Share Is Likely To Reach At A CAGR Value Of Around 3.10% By 2028: https://www.fnfresearch.com/nitric-acid-market
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
USA: +1 347 690-0211 | UK: +44 2032 894158 | Japan: +81 50 5806 9039 | India: +91 73877 19999
Email: sales@fnfresearch.com | Web: https://www.fnfresearch.com
Follow Us on - LinkedIn | Twitter | Facebook
Below, we share with you three healthcare mutual funds, namely FSHCX, VGHCX and PHLAX. Each has earned a Zacks Mutual Fund Rank #1.
General Electric (GE) aims to streamline its onshore wind unit, which is grappling with weak demand, raw material cost inflation and delays caused by supply chain disruptions.
Gold futures settled lower on Friday, but notched a second straight weekly gain. A "stronger U.S. jobs report means talks about the [Federal Reserve] potentially pivoting [away from interest-rate hikes] have all but ended," said Fawad Razaqzada, market analyst at City Index and FOREX.com. "The dollar is thus likely to remain supported on the dips, with investors also likely to be discouraged from the stock and gold markets, with the latter particularly looking less attractive because of the fres
Barrington Research analyst James C.Goss reiterated an Outperform rating on the shares of IMAX Corp (NYSE: IMAX) with a price target of $20. As theatres have reopened and feature film releases have become more numerous, IMAX U.S. box office has generally performed closer to its 2019 benchmark than the broader domestic industry, noted the analyst. The blockbuster-heavy slate, consumer preference for a premium experience, and typical one or two-week runs on IMAX screens play into the performance.
California-based Rivian is recalling about 13,000 vehicles after it discovered that a fastener connecting the front upper control arm and steering knuckle may not have been "sufficiently torqued" in some vehicles, a company spokesperson said in a statement. Electric vehicle maker has so far produced a total of 14,317 vehicles this year. Rivian notified the affected customers about the recall after it became aware of seven reports potentially related to the structural issue of torqued fastener, the company said.
Tilray Brands, Inc. (TLRY) delivered earnings and revenue surprises of -33.33% and 1.59%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?
U.S. employers hired more workers than expected in September, while the unemployment rate dropped to 3.5% from 3.7% the previous month, pointing to a tight labor market which keeps the Federal Reserve on its aggressive monetary policy tightening campaign for a while. With the labor market still tight, wage gains remained solid. BONDS: The yield on 10-year Treasury note jumped was last up 7.8 basis points at 3.902%; The two-year U.S. Treasury yield, was up 7.7 basis points at 4.327%.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here is how Jakks Pacific (JAKK) and PowerSchool Holdings (PWSC) have performed compared to their sector so far this year.
PEP's stock has performed considerably better than the broader market this year and may very well help investors fight inflation.
The Labor Department said the company fired them over suspicions they shared information with The Wall Street Journal. Exxon said it fired them for other reasons and that their allegations were false.
Electric-vehicle makers in Asia and the companies that supply them are rushing to capital markets to raise money, as they try to take advantage of a surge in demand for energy-efficient automobiles.
What to watch in markets on Friday, October 7, 2022.
A stock market rally attempt survives a volatile week, but lays out clear lines of caution as Q3 reporting season bears down.
Wall Street fell sharply on Friday following a solid jobs report for September that increased the likelihood the Federal Reserve will barrel ahead with an interest rate hiking campaign many investors fear will push the U.S. economy into a recession. The Labor Department reported the unemployment rate fell to 3.5%, lower than expectations of 3.7%, in an economy that continues to show resilience despite the Fed's efforts to bring down high inflation by weakening growth. Money markets raised to 92% the probability of a fourth straight 75 basis-point rate hike when Fed policymakers meet on Nov. 1-2, up from 83.4% before the data.
Schlumberger saw its IBD SmartSelect Composite Rating rise to 96 Friday, up from 94 the day before. The upgrade means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength. Schlumberger is not currently near a proper entry, as it is still building the right side of a cup pattern.
Paylocity and three other top-ranked software stocks in the IBD 50 have seen bullish price action in recent weeks.
The deal with Motional marks Uber's (UBER) return to the robotaxi business.
The stock market is in no man’s land. Cody Willard says that, five years from now, investors will celebrate having bought stocks as other investors sold into the bear market. In an interview on CNBC’s Squawk Box, Michael Novogratz discussed the Federal Reserve’s interest rate hikes.
FedEx Corp (NYSE: FDX) plans to slash the volume outlook for one of its divisions handling e-commerce deliveries. The company arrived at the decision, Reuters reported, as its customers are expected to ship fewer packages during the holiday season. Related: Are FedEx's Troubles Indicative Of A Recession? Perhaps Not For UPS, DHL And Amazon The message was conveyed to the company's 6,000 independent contractors that handle delivery and trucking for FedEx Ground in the U.S. and Canada through an i